Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Merck KGaA and Pfizer alliance begins lung cancer study

April 21, 2015 Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo

Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …
News

Daiichi Sankyo to sell Sun Pharma stake

April 21, 2015 Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics

Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …
News

Novartis MS drug scores positive late-stage trial result

April 21, 2015 Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis

People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …
News

UK firm unveils respiratory apps

April 21, 2015 Medical Communications, Sales and Marketing Activ8rlives, Aseptika, SENSOR, communications, digital

Cambridgeshire-based healthcare tech firm Aseptika has made its suite of apps available to support studies in respiratory research. The UK …
News

Four join the ranks of IDEA Pharma

April 21, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anastasia Liapis, Cindy Peché, IDEA Pharma, Louise Ward, Vivian Huang

IDEA Pharma has made four new appointments in Louise Ward as project manager and Cindy Peché as head of group …
Appointment

Sanofi sues decision aid maker for ‘injurious falsehood’

April 20, 2015 Medical Communications, Sales and Marketing Diagnosia, Sanofi, metamizole, tech

A tech start-up says it is being sued by pharma giant Sanofi for presenting facts about a drug’s side effects …
News

Merck seeks new Keytruda indication in US

April 20, 2015 Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab

Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …
News

Round one to Pfizer in Zoloft lawsuit battle

April 20, 2015 Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline

Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …
News

AstraZeneca lung drug shows promise

April 20, 2015 Sales and Marketing AZ, AZD9291, AstraZeneca, European Lung Cancer Congress, NSCLC, Orphan

AstraZeneca’s non-small cell lung cancer offering AZD9291 has been shown to delay disease progression by over a year. Data presented …
News

What you need to know about the EU Clinical Trial Regulation

April 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EU Clinical Trial Regulation, EU-CTR, Virginia Acha

 Where did the EU Clinical Trial Regulation come from? The EU Clinical Trial Regulation (EU-CTR) was approved in April 2014 …
Feature

Celgene appoints former Cubist chief executive

April 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, cubist, michael bonney

Celgene has elected pharma veteran Michael Bonney to join its board of directors. Bonney served as chief executive and board …
Appointment

GSK sees further US job losses following Novartis deal

April 17, 2015 Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring

Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …
News

AstraZeneca bags another FDA orphan status in cancer

April 17, 2015 Sales and Marketing AstraZeneca, Cancer, FDA, GlaxoSmithKline, mekinist, melanoma, oncology, selumetinib, trametinib

The FDA has granted AstraZeneca’s cancer medicine selumetinib orphan drug designation for the treatment of uveal melanoma. The company will …
News

FDA approves generic Copaxone for multiple sclerosis

April 17, 2015 Sales and Marketing FDA, Sandoz, Teva, glatiramer acetate injection, glatopa

The FDA has signed-off on the first generic version of Copaxone to treat people with relapsing forms of multiple sclerosis …
News

Merck chief executive replaces Pfizer boss as PhRMA chairman

April 17, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing George Scangos, Ian Read, Joaquin Duato, Kenneth Frazier, PhRMA

Chairman and chief executive of Merck Kenneth Frazier is to replace Pfizer boss Ian Read as chairman at the Pharmaceutical …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026